Showing results (51-60 of 564) with videos related to
Sort By:
Pageof 57
Lung|January 1, 1996
Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonistsA Lindén, K F Rabe, C G LöfdahlAmerican Journal of Respiratory and Critical Care Medicine|May 10, 2013
Phosphodiesterase-4 inhibitor therapy for lung diseasesBianca Beghè, Klaus F Rabe, Leonardo M FabbriPulmonary Pharmacology & Therapeutics|April 9, 2017
Role of dual bronchodilators in COPD: A review of the current evidence for indacaterol/glycopyrroniumJoachim H Ficker, Klaus F Rabe, Tobias WelteZeitschrift Fur Urologie Und Nephrologie|September 1, 1983
[Significance of radioisotope nephrography and sequential scintigraphy of the kidney for the indication of nephropexy in a hypermobile kidney]F Rabe, H J Otto, G W MüllerThe Journal of Pediatrics|March 1, 1980
The effect of ACTH therapy upon infantile spasmsW D Singer, E F Rabe, J S HallerClinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 24, 1998
Histamine hypersensitivity induced by passive sensitization of human bronchus: effect of serum IgE depletionN Watson, E Rühlmann, H Magnussen, et al.Primary Care Respiratory Journal : Journal of the General Practice Airways Group|November 9, 2019
COPD: The role of primary care in effective diagnosis, treatment and managementOnno Cp van Schayck, Klaus F Rabe, Michael RudolfPulmonary Pharmacology & Therapeutics|June 9, 2005
The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lungG Sandra Tjabringa, Klaus F Rabe, Pieter S HiemstraAmerican Journal of Diseases of Children (1960)|October 1, 1975
Skull volume in infants. Methodology, normal values, and applicationF B Buda, J C Reed, E F RabeInternational Journal of Chronic Obstructive Pulmonary Disease|January 22, 2016
Roflumilast: a review of its use in the treatment of COPDJadwiga A Wedzicha, Peter Ma Calverley, Klaus F RabePageof 57